References
- Shalita AR, Myers JA, Krochmal L, Yaroshinsky A. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris. J. Drugs Dermatol.4(1), 48–56 (2005).
- Strauss JS, Krowchuk DP, Leyden JJ et al. Guidelines of care for acne vulgaris management. J. Am. Acad. Dermatol.56(4), 651–663 (2007).
- Verfaille CJ, Coel M, Boersma IH, Mertens J, Borgers M, Roseeuw D. Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study. Br. J. Dermatol.157(1), 122–126 (2007).
- Skidmore R, Kovach R, Walker C et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch. Dermatol.139(4), 459–464 (2003).
- Fleischer ADS, Stough D, Plott RT; for the solodyne Phase 2 and Phase 3 Study groups. Safety and efficacy of a new extended-release formulation of minocycline. Cutis78, 21–31 (2006).
- Leyden JJ, Krochmal L, Yaroshinsky A. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris. J. Am. Acad. Dermatol.54(1), 73–81 (2006).
- Thiboutot DM, Weiss J, Bucko A et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J. Am. Acad. Dermatol.57(5), 791–799 (2007).
- Thiboutot DM, Willmer J, Sharata H, Halder R, Garrett S. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris. Clin. Pharmacokinet.46(8), 697–712 (2007).
- Draelos ZD, Carter E, Maloney JM et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J. Am. Acad. Dermatol.56(3), 439.e1–439.e10 (2007).
- Glaich AS, Friedman PM, Jih MH, Goldberg LH. Treatment of inflammatory facial acne vulgaris with combination 595-nm pulsed-dye laser with dynamic-cooling-device and 1,450-nm diode laser. Lasers Surg. Med.38(3), 177–180 (2006).
- Goldberg DJ, Russell BA. Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris. J. Cosmet. Laser Ther.8(2), 71–75 (2006).
- Friedman PM, Jih MH, Kimyai-Asadi A, Goldberg LH. Treatment of inflammatory facial acne vulgaris with the 1450-nm diode laser: a pilot study. Dermatol. Surg.30(2 Pt 1), 147–151 (2004).
- Taglietti M, Hawkins CN, Rao J. Novel topical drug delivery systems and their potential use in acne vulgaris. Skin Therapy Lett.13(5), 6–8 (2008).